India's Piramal To Share With Employees Sale Of Unit To Abbott
This article was originally published in PharmAsia News
Executive Summary
Piramal Healthcare's $3.7 billion sale of its formulations business to U.S.-based Abbott Laboratories means cash bonuses equal to as much as six months of salary for many of Piramal's 8,000 employees in India